Everything below concerns SR9009. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-11-29. Numbers and descriptions here follow the published literature rather than marketing material.
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C or lower | Desiccated and protected from light |
| Common analytical method | LC-MS/MS | Detects parent drug and metabolites |
| Solubility class | Lipophilic; soluble in organic solvents | Low aqueous solubility |
| Molecular weight | 437.94 g/mol | Calculated from reported formula |
| Synonyms | SR9009; REV-ERB agonist | Code name used in scientific literature |
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
In analytical chemistry, a standard solution (titrant or titrator) is a solution containing an accurately known concentration. Standard solutions are generally prepared by dissolving a solute of known mass into a solvent to a precise volume, or by diluting a solution of known concentration with more solvent. A standard solution ideally has a high degree of purity and is stable enough that the concentration can be accurately measured after a long shelf time. Making a standard solution requires great attention to detail to avoid introducing any risk of contamination that could diminish the accuracy of the concentration. For this reason, glassware with a high degree of precision such as a volumetric flask, volumetric pipette, micropipettes, and automatic pipettes are used in the preparation steps. The solvent used must also be pure and readily able to dissolve the solute into a homogenous solution. Standard solutions are used for various volumetric procedures, such as determining the concentration of solutions with an unknown concentration in titrations. The concentrations of standard solutions are normally expressed in units of moles per litre (mol/L, often abbreviated to M for molarity), moles per cubic decimetre (mol/dm3), kilomoles per cubic metre (kmol/m3), grams per milliliters (g/mL), or in terms related to those used in particular titrations (such as titres).
=== Climate === Similar to the majority of Western Oregon, Albany's weather is considered to be mild. Albany has generally warm and dry summers during which precipitation drops to 0.4 inches (10 mm) in July and temperatures peak at an average of 80.8 °F (27 °C) in August. The record high temperature in Albany was 110 °F (43 °C) on June 27 during the 2021 Western North America heat wave. Winters in Albany are cool and wet. The month with the most precipitation is December with 6.8 inches (170 mm). The coldest month is January, with an average low just above freezing at 33.6 °F (1 °C). The record low temperature was recorded in 1972 at −7 °F (−22 °C). Albany and the surrounding area was left devastated by the Columbus Day Storm of October 1962.
=== Available forms === Tazarotene is available in several topical formulations, including gels, creams, foams, and lotions, with concentrations ranging from 0.045% to 0.1%. Tazarotene was first approved in 1997 as a 0.05% and 0.1% gel, followed by 0.05% and 0.1% creams in 2000. In 2012, a 0.1% aerosol foam was introduced to provide easier application to hair-bearing or large surface areas of the skin. A 0.045% lotion was approved in 2019, which utilizes a polymeric emulsion technology to stabilize the active ingredient at a lower concentration with increased absorption. Tazarotene is also available as a fixed-dose combination drug in the topical formulation of halobetasol/tazarotene for use in psoriasis.
=== Scotland to England in 1988 === On 1 May 1988, he set off again from John o' Groats, this time walking through the West Highlands, down the Pennine Way and then south to Land's End: a distance of 1,100 miles (1,800 km) in seven weeks. As part of the training for this walk he ran the gruelling Snowdonia Marathon, in a time of 4 hours and 40 minutes. The walk through Scotland and England raised £2,000 for Macmillan Cancer Support.
== Liquid-phase reactions == Chemiluminescence was first observed with lophine (triphenylimidazole). When in basic solution, this compound converts to imidazolate, which reacts with oxygen to eventually give a dioxetane. Fragmentation of dioxetane gives the excited state of an anionic diamide.
Sources: en.wikipedia.org
Chief Executive Officer, Key Assets Europe. For services to Fostering. Rowan Edwin Crozier. Chief Executive Officer, C Brandauer & Co. For services to Manufacturing and Enterprise. Dr. Donald Murray Cruickshank. General Practitioner, Upper Deeside. For services to the Medical Profession and to the community of Braemar, Aberdeenshire. Diana Jane Andrews Cunningham. Peer Trainer, Sussex Recovery College. For services to Mental Health. Suzette Louise Davenport, QPM. Chair, National Driver Offending Retraining Scheme. For services to Road Safety. Jessica Miriam Bryson Davidson. Senior Clinical Forensic Charge Nurse. For services to Forensic Nursing and to Victim Support in Scotland. Donna Marie Dawber. News and Campaigns Manager, Merseyside Police. For services to Law and Order. Dr. Edward James Day. Clinical Reader in Addiction Psychiatry, University of Birmingham. For services to Vulnerable People. Shaun Andrew Day. Headteacher, The Unicorn School, Abingdon, Oxfordshire. For services to Education. Paula Rosemary Deas. Deputy Chief Executive, Coventry and Warwickshire Local Enterprise Partnership. For services to the community in the West Midlands. Keith Deller. For charitable services to the community in Suffolk. Jack Robert Clarke Deverson. Co-Founder and Managing Director, Evidence Based Education. For services to Education. Ruth Heather Devine. Route Panel Member, Institute for Apprenticeships and Technical Education. For services to Further Education and Apprenticeships. Deborah Heather Dixon (Deborah Williams). For services to the community in Poole, Dorset.
== Detection of citrullinated peptides and proteins == Citrullinated peptides and proteins can be detected using antibodies targeting the citrullinated residues, or detected using mass spectrometry-based proteomics technologies. Citrullination of arginine results in a monoisotopic mass increase of +0.984016 Da, which can be measured with mass spectrometry. The mass shift is close to the mass difference between the different peptide isotopes of +1.008665 which can be mistaken for a citrullinated peptide, especially on low-resolution instruments. However, this is less of an issue with modern high resolution/high accuracy mass spectrometers. Furthermore, the mass shift is identical to the mass shift caused by deamidation of the amino acid asparagine or glutamine side chain, which are common modifications. Citrulline residues can be chemically modified with butanedione or by biotinylation prior to analysis, leading to a different mass shift, and this strategy has successfully been used to facilitate identification by mass spectrometry. Another approach is to utilize the neutral loss of isocyanic acid (HNCO) from citrulline residues when submitted to low energy collision induced dissociation fragmentation in mass spectrometers. The loss causes a mass shift of −43.0058 Da, which can be utilized by mass spectrometers to predominantly select citrullinated peptides for fragmentation (sequencing). Finally, the loss of positive charge at physiological pH caused by citrullination can be utilized. Prior to bottom-up proteomics analysis, proteins are enzymatically cleaved into peptides.
=== Pulse vaccination strategy === This strategy repeatedly vaccinates a defined age-cohort (such as young children or the elderly) in a susceptible population over time. Using this strategy, the block of susceptible individuals is then immediately removed, making it possible to eliminate an infectious disease, (such as measles), from the entire population. Every T time units a constant fraction p of susceptible subjects is vaccinated in a relatively short (with respect to the dynamics of the disease) time. This leads to the following impulsive differential equations for the susceptible and vaccinated subjects:
== Contribution, awards and achievements == He was awarded the Fellowship of Rockefeller Foundation Fellow in USA during 1960–61; Commonwealth Medical Fellowship and then Wellcome Research Fellowship in England during the 1970s. In London at the National Institute for Medical Research, he worked on mechanism of action of Pyrogen and in the field of thermoregulation, with Wilhelm Feldberg (1900–1993), a German-British-Jewish pharmacologist and biologist. Wilhelm Feldberg assisted many research workers who came to England as a part of their Commonwealth Medical Fellowship and Wellcome Research Fellowship. Under these Fellowships, Saxena and Feldberg published many papers during the 1970s. In total, Saxena has approximately 145 published research papers. He wrote Hospital Formulary in 1969 and a book-cum-manual for practical pharmacy and experimental pharmacology laboratory. He had been founding member of many academic bodies such Indian Pharmacological Society, Association of Physiologists and Pharmacologists of India, Indian Medical Association, Indian Academy of Neurosciences and Indian Association for the Advancement of Medical Education in India. Indian National Science Academy (INSA) elected him Fellow (FNA) in 1987.
Sources: en.wikipedia.org
Liquid chromatography-tandem mass spectrometry is a common approach. It can detect the parent compound and its metabolites in biological matrices.
Research samples are typically kept frozen, desiccated, and protected from light. Stock solutions are often aliquoted to reduce freeze-thaw cycles.
High-performance liquid chromatography and nuclear magnetic resonance are standard for purity and identity. Mass spectrometry confirms molecular weight.
SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.